Cargando…
Targeted activation of diverse CRISPR-Cas systems for mammalian genome editing via proximal CRISPR targeting
Bacterial CRISPR–Cas systems comprise diverse effector endonucleases with different targeting ranges, specificities and enzymatic properties, but many of them are inactive in mammalian cells and are thus precluded from genome-editing applications. Here we show that the type II-B FnCas9 from Francise...
Autores principales: | Chen, Fuqiang, Ding, Xiao, Feng, Yongmei, Seebeck, Timothy, Jiang, Yanfang, Davis, Gregory D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5385574/ https://www.ncbi.nlm.nih.gov/pubmed/28387220 http://dx.doi.org/10.1038/ncomms14958 |
Ejemplares similares
-
Chromothripsis as an on-target consequence of CRISPR-Cas9 genome editing
por: Leibowitz, Mitchell L., et al.
Publicado: (2021) -
Fast and cloning‐free CRISPR/Cas9‐mediated genomic editing in mammalian cells
por: Manna, Paul T., et al.
Publicado: (2019) -
Off-target effects in CRISPR/Cas9 gene editing
por: Guo, Congting, et al.
Publicado: (2023) -
Methodologies and Challenges for CRISPR/Cas9 Mediated Genome Editing of the Mammalian Brain
por: Nishizono, Hirofumi, et al.
Publicado: (2020) -
Synergistic engineering of CRISPR-Cas nucleases enables robust mammalian genome editing
por: Chen, Yangcan, et al.
Publicado: (2022)